Sana Biotechnology, Inc.

SANA

Sana Biotechnology, Inc.

SANA

Insider Sentiment (TTM):

Last Purchase:2024-02-08Last Sale:2025-01-08Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:162,393,506Shares Outstanding:276,856,000Institutional Ownership Pct.:58.66%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	57	84	72	103	71	96	128	127	135	177	134	168
Marketable Securities Current	103	17	67	50	1	9	25	72	117	134	72	100
Restricted Cash Current	4	4	4	4	4	4	4	4	4	4	4	4
Prepaid Expense And Other Assets Current	6	6	6	5	6	4	4	7	8	6	4	7
Assets Current	171	112	149	162	83	113	161	210	263	321	214	280
Property Plant And Equipment Net	25	26	27	30	33	74	77	83	86	82	71	68
Operating Lease Right Of Use Asset	35	36	38	41	43	55	58	61	63	72	75	77
Intangible Assets Net Excluding Goodwill	59	59	59	59	59	59	59	59	59	59	59	59
Goodwill	141	141	141	141	141	141	141	141	141	141	141	141
Other Assets Noncurrent	1	1	3	3	3	4	5	6	6	7	6	6
Assets	432	374	417	435	362	445	501	559	619	681	565	631
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	2	2	2	2	1	5	3	4	6	4	10
Employee Related Liabilities Current	9	8	13	11	9	9	14	18	16	14	24	24
Accrued Liabilities And Other Liabilities	8	8	9	8	8	10	13	15	21	20	23	19
Operating Lease Liability Current	15	15	15	14	14	13	13	11	10	13	13	13
Business Combination Contingent Consideration Liab…	91	54	40	-	-	-	0	-	-	-	-	-
Liabilities Current	124	86	79	36	33	33	45	47	51	53	64	67
Operating Lease Liability Noncurrent	59	60	64	68	72	78	82	85	89	93	91	83
Business Combination Contingent Consideration Liab…	60	81	84	115	117	111	109	112	112	115	110	103
Other Liabilities Noncurrent	9	10	11	8	8	9	10	7	7	-	-	-
Liabilities	277	254	256	240	239	236	251	267	279	306	278	266
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	2,114	2,015	2,010	1,985	1,871	1,863	1,855	1,848	1,836	1,821	1,626	1,616
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,960	-1,896	-1,849	-1,790	-1,748	-1,654	-1,605	-1,556	-1,496	-1,446	-1,338	-1,250
Stockholders Equity	155	119	161	195	123	209	251	292	340	375	288	366
Liabilities And Stockholders Equity	432	374	417	435	362	445	501	559	619	681	565	631
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	750	750	750	750	750	750	750	750	750	750	750	750
Common Stock Shares Issued	299	270	267	262	231	225	224	223	222	221	198	197
Shares Outstanding	299	270	267	262	231	225	224	223	222	221	198	197

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-24.72%	12.64%	-12.08%	-	-	-	-	-	-	-	-	-
2025	19.89%	55.25%	173.48%	1.37%	35.62%	69.52%	6.17%	8.89%	19.26%	-29.52%	-16.28%	-21.88%
2024	-20.97%	-42.47%	-32.56%	29.83%	-8.15%	-19.31%	-7.49%	-46.42%	12.48%	-36.46%	-34.30%	2.53%
2023	-	-	-	-	-	-	20.96%	22.16%	63.77%	-8.86%	-24.20%	-13.05%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.38	1.29	1.89	4.55	2.47	3.40	3.54	4.47	5.20	6.07	3.31	4.19
Quick Ratio	1.33	1.22	1.81	4.43	2.30	3.28	3.44	4.32	5.04	5.95	3.24	4.09
Working Capital	46.88M	25.43M	69.95M	126.25M	49.06M	79.58M	115.38M	163.15M	212.76M	268.36M	149.03M	212.88M
Leverage & Debt
Debt to Equity	1.79	2.13	1.59	1.23	1.95	1.13	1.00	0.91	0.82	0.82	0.97	0.73
Interest Coverage TTM	-50.18	-65.22	-65.05	-56.76	-44.49	-25.23	-26.05	-27.08	-21.39	-29.08	-29.50	-32.22
Debt Ratio	0.64	0.68	0.61	0.55	0.66	0.53	0.50	0.48	0.45	0.45	0.49	0.42
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.72	-0.87	-0.96	-0.90	-1.06	-0.88	-1.16	-1.30	-1.04	-1.42	-1.46	-1.37
Free Cash Flow Per Share TTM	-0.49	-0.48	-0.57	-0.42	-0.57	-0.94	-1.11	-1.17	-1.22	-1.26	-1.41	-1.46
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-16.00%	15.96%	-8.47%	-23.35%	2.97%	-32.38%	-5.82%	10.97%	-32.29%	-3.61%	5.11%	-8.07%
EPS Growth (1Y)	-32.27%	-0.49%	-16.55%	-30.73%	1.26%	-38.16%	-20.65%	-7.15%	-44.39%	-15.17%	1.76%	-11.65%
Valuation Metrics
P/E TTM	-4.87	-3.29	-4.22	-3.95	-2.58	-1.91	-1.41	-3.20	-5.23	-7.04	-2.80	-2.77
P/B TTM	6.68	6.69	6.41	4.73	5.31	1.91	1.50	3.35	3.77	5.79	2.76	2.08
Market Cap	1.03B	797.35M	1.03B	924.75M	650.86M	399.13M	376.35M	979.31M	1.28B	2.17B	793.73M	762.30M
Enterprise Value	970.61M	709.35M	954.60M	817.20M	575.39M	298.81M	244.95M	848.49M	1.14B	1.99B	656.38M	590.02M
Calculated Values
Free Cash Flow TTM	-146.19M	-134.14M	-145.26M	-110.55M	-136.99M	-223.90M	-256.58M	-274.99M	-284.86M	-273.64M	-273.61M	-288.28M
Net Debt	-61.27M	-88.00M	-76.07M	-107.55M	-75.47M	-100.33M	-131.40M	-130.83M	-138.79M	-180.89M	-137.35M	-172.28M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-01-08Sale

Owner: Fmr, Llc

Title: -

Shares: 290,912

Price/Share: $6.64

Value: $1,931,655.68

Shares Owned: 4,541,511

Relationship: TenPercentOwner,Other

Ownership: Indirect

2024-09-25Sale

Owner: Mulligan, Richard

Title: -

Shares: 150,000

Price/Share: $3.89

Value: $583,500.00

Shares Owned: 2,698,121

Relationship: Director

Ownership: Direct

2024-03-08Sale

Owner: Yang, Patrick Y

Title: -

Shares: 25,000

Price/Share: $9.45

Value: $236,250.00

Shares Owned: 149,250

Relationship: Director

Ownership: Direct

2024-02-08Purchase

Owner: Arch, Venture Fund X, L.P…

Title: -

Shares: 1,818,181

Price/Share: $5.50

Value: $9,999,995.50

Shares Owned: 12,446,022

Relationship: TenPercentOwner

Ownership: Indirect

2024-02-08Purchase

Owner: Burow, Kristina, Gillis S…

Title: -

Shares: 1,818,181

Price/Share: $5.50

Value: $9,999,995.50

Shares Owned: 12,446,022

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-01-08	Fmr, Llc	TenPercentOwner,Other	-	Indirect	Sale	290,912	6.64	$1,931,655.68	4,541,511	4
2024-09-25	Mulligan, Richard	Director	-	Direct	Sale	150,000	3.89	$583,500.00	2,698,121	4
2024-03-08	Yang, Patrick Y	Director	-	Direct	Sale	25,000	9.45	$236,250.00	149,250	4
2024-02-08	Arch, Venture Fund X, L.P…	TenPercentOwner	-	Indirect	Purchase	1,818,181	5.50	$9,999,995.50	12,446,022	4
2024-02-08	Burow, Kristina, Gillis S…	TenPercentOwner	-	Indirect	Purchase	1,818,181	5.50	$9,999,995.50	12,446,022	4
2024-02-08	Nelsen, Robert	Director,TenPercentOwner	-	Indirect	Purchase	1,818,181	5.50	$9,999,995.50	12,446,022	4
2023-12-15	Hordo, Christian	Officer	EVP, Chief Business Officer	Direct	Sale	75,000	4.00	$300,000.00	867,455	4
2023-06-07	Flagship, V Venturelabs R…	TenPercentOwner	-	Indirect	Sale	200,000	6.24	$1,248,000.00	1,380,277	4
2023-05-26	Flagship, Ventures Fund V…	TenPercentOwner	-	Indirect	Sale	82,000	6.23	$510,860.00	1,425,334	4
2022-03-21	Yang, Patrick Y	Director	-	Direct	Purchase	28,000	7.30	$204,400.00	174,250	4
2022-02-18	Macdonald, James J.	Officer	EVP & General Counsel	Direct	Sale	333	6.28	$2,091.24	429,417	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

58.66%

Inst. Shares: 162,393,506

Shares Outstanding: 276,856,000

2025-12-31

62.31%

Inst. Shares: 157,789,752

Shares Outstanding: 253,234,000

2025-09-30

62.58%

Inst. Shares: 163,018,011

Shares Outstanding: 260,494,000

2025-06-30

59.44%

Inst. Shares: 141,709,993

Shares Outstanding: 238,409,000

2025-03-31

61.28%

Inst. Shares: 145,598,071

Shares Outstanding: 237,578,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	162,393,506	276,856,000	58.66%
2025-12-31	157,789,752	253,234,000	62.31%
2025-09-30	163,018,011	260,494,000	62.58%
2025-06-30	141,709,993	238,409,000	59.44%
2025-03-31	145,598,071	237,578,000	61.28%
2024-12-31	153,833,899	230,891,000	66.63%
2024-09-30	149,187,616	235,412,000	63.37%
2024-06-30	142,752,031	234,440,000	60.89%
2024-03-31	135,805,683	217,290,000	62.50%
2023-12-31	119,645,846	194,541,000	61.50%
2023-09-30	118,210,026	196,978,000	60.01%
2023-06-30	128,123,380	192,540,000	66.54%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Sana Biotechnology, Inc. (SANA) — SEC Financial Statements & Analysis

Sana Biotechnology, Inc. (SANA) is a biological products, (no diagnostic substances) company, incorporated in DE. Sana Biotechnology, Inc. trades on Nasdaq as: SANA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Sana Biotechnology, Inc. reported a Debt-to-Equity ratio of 1.79x, a Price-to-Book (P/B) ratio of 6.68x (TTM), at a market cap of $1.03B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 1.79x
P/B TTM: 6.68x
Market Cap: $1.03B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sana Biotechnology, Inc. in?

Sana Biotechnology, Inc. (SANA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is SANA's market cap?

Sana Biotechnology, Inc. (SANA) has a market capitalization of $1.03B as of 2026-06-30.

What exchange does SANA trade on?

Sana Biotechnology, Inc. (SANA) trades on the Nasdaq.

Where is Sana Biotechnology, Inc. incorporated?

Sana Biotechnology, Inc. is incorporated in DE.